Actos
pioglitazone
- Strength
- 45 mg/1
- Form
- Tablet
- Class
- Peroxisome Proliferator Receptor alpha …
Takeda Pharmaceuticals America, Inc.
Listed by NorthStar RxLLC
| Dosage form | Tablet |
|---|---|
| Route | Oral |
| Drug class | Peroxisome Proliferator Receptor alpha Agonist; Peroxisome Proliferator Receptor gamma Agonist; Thiazolidinedione |
| Approval route | ANDA — approved generic |
| NDC code | 16714-647 |
| FDA application | ANDA202467 |
| RxNorm concept | 312440 |
| Package sizes listed | 3 |
| Marketed since | August 2022 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
pioglitazone
Takeda Pharmaceuticals America, Inc.
pioglitazone
Takeda Pharmaceuticals America, Inc.
pioglitazone
Takeda Pharmaceuticals America, Inc.
Major Pharmaceuticals
Macleods Pharmaceuticals Limited
NuCare Pharmaceuticals,Inc.
AvKARE
Rising Pharma Holdings, Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.